Therapeutic effect of red laser to promote relieve of headache
- Conditions
- Patients with migraine or e, a pathological condition of nervous system.
- Registration Number
- RBR-5ctpcr
- Lead Sponsor
- niversidade de Araraquara
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Only participants who meet the criteria required by the International Headache Society for migraine-type headache (CLASS. SIC, 2014); age over 18 years and above 80 years; complain of headache for more than six months and recurrent episodes; report 3 episodes of migraine per month; reported onset of migraine before age 50; have at least 3 months of history and 2-8 attacks per month, with progression of moderate to severe pain symptoms lasting more than 2h; report headache medication use 14 days / month within 3 months prior to study; If they use migraine prophylaxis, you should be stable for 30 days before and throughout the study.
Users of cardiac pacemakers, history of epilepsy, cardiac arrhythmias, being in gestational period; scheduled or undergoing surgical procedures during treatment or 20 days prior to the start of the study; have other primary headache conditions with 15 or more days of pain per month; use opioids for more than 10 days within 30 days prior to screening; have systemic disease or neurological or psychiatric condition.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of headache intensity, presence of triggers, pain sites or other factors during migraine occurrence, verified by pain diary before, during and after treatment.
- Secondary Outcome Measures
Name Time Method To assess migraine-related disability with the Migraine Disability Assessment Program (MIDAS) Questionnaire (FRAGOSO, 2002) at the end of treatment.;To evaluate the presence and severity of allodynia through the 12 - Item Allodynia Symptom Checklist (ASC - 12) - Brazilian Version (FLORENCE et al., 2012) at the end of treatment.;To assess patient satisfaction and change perception regarding their disease condition by the Global Patient Impression Scale (PGIC) (HURST; BOLTON, 2004) at the end of treatment.;Changes in the level of oxidative stress (Superoxide dismutase - SOD, Catalase, TIOIS) and nitrosative stress (nitrite and nitrate) in the blood before and after treatment.